Scientific Analysis Laboratories (SAL) welcomes Simon Cliff as Business Development Manager

Cliff has more than 20 years of experience of business development in the laboratory testing industry

Scientific Analysis Laboratories (SAL), part of the Concept Life Sciences Group, has hired Simon Cliff as Business Development Manager.

SAL, which offers global accredited analytical services for a range of sectors, is one of the largest independent laboratories in Europe with five sites across the UK.

Cliff joins the team with more than 20 years of experience of business development in the laboratory testing industry. He has previously worked for Eurofins, Exova, QuadraChem Laboratories (QCL) and Alcontrol Laboratories.

Cliff will focus on working with clients to help them develop new scientific solutions so that they can add value to their product ranges, and make full use of the wide range of analytical services on offer from SAL's laboratories. He will also help the group to grow its offering within the food and beverage sectors.

You may also like

Manufacturing

Lonza opens capsule drug development-focused site at its Colmar facility

The new addition to the French site will allow customers access to experts and technologies ideal for capsule formulation and development
Research & Development

Adenosine A2a receptor: novel biophysical fragment screening using polymer-encapsulated nanodiscs

Fragment screening is a useful method for hit identification as it offers an efficient and flexible way to identify novel therapeutic starting points that other techniques may have missed because of the small molecular size of the fragments
Research & Development

Roche's antiviral Xofluza reduces flu transmission in Phase III trial

Topline results suggest that Xofluza could be used to reduce the transmission of seasonal influenza
Research & Development

RSSL opens 3D imaging and metrology laboratory for end-to-end research and analysis

The laboratory will offer, micro-CT, microscopy and spectroscopy services for its pharmaceutical and medical device partners
Manufacturing

Ensuring cGMP compliance in cell and gene therapy manufacturing

3P discusses how companies can scale up their CGT manufacturing protocols while remaining compliant with stringent global regulations
Manufacturing

Quotient Sciences and Vasa Therapeutics announce dosing of first subjects in VS-041 novel heart failure trial

The trial is designed to evaluate the safety, tolerability, and pharmacokinetics of VS-041 in healthy volunteers
Research & Development

How excipient testing allows for safe pharmaceutical manufacturing

Excipients play a fundamental role in API delivery, and John Welch, Butterworth's Associate Director of Business Operations, believes that their testing is key to ensuring the safety of pharmaceutical products
Subscribe now